The right medication depends on your medical history, your weight loss goals, how much weight you need to lose, and what you can realistically afford over the long term
Ozempic (semaglutide) is a GLP-1 receptor agonist licensed in the UK for type 2 diabetes, working by stimulating insulin secretion and slowing gastric emptying
This is because the body may get used to changes, and metabolism is different for each person
When doses increase too quickly, the digestive system has less time to adapt, which can intensify symptoms
Effective for Type 2 Diabetes : Helps reduce blood sugar levels in adults with type 2 diabetes
In research models, GLP-1 receptor activation is associated with glucose-dependent insulin secretion, suppression of glucagon release, slowed gastric emptying, and reduced food intake through central appetite-regulating circuits